What is OVID's dilution risk score?

OVID has a latest available DilutionScore record of 75/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for OVID, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for OVID?

DilutionWatch tracks 25 SEC filing types for OVID including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect OVID shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For OVID, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for OVID tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for OVID. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

OVID Dilution Risk Score: 75/100 (HIGH)

Score Breakdown

📋 Offering Ability

72

💰 Cash Runway

95

📊 Float Risk

7

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

🌩️

Severe

Multiple high-probability dilution events detected

model est. 57%

💰 Capital Raise model 93%

• Critical: only 2.6 months cash remaining

• Active shelf registration ($60M, 12% of market cap)

🔄 Reverse Split model est. 30%

• 52-week low $0.27 has breached $1

• Only 3 months cash — financial pressure

📉 Score Deterioration model 10%

• Score in HIGH risk zone (75/100)

🔔 Track OVID — Get forecast alerts →

Market Data

Market Cap$509.53M

Shares Outstanding195.30M

Float161.29M

Cash$11.33M

Debt$13.07M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 83.6% shares (2026Q1 vs prior)

104 institutional holders · 122.49M shares

#1 JANUS HENDERSON GROUP PLC 21.43M shares

#2 RA CAPITAL MANAGEMENT, L.P. 10.71M shares

#3 Affinity Asset Advisors, LLC 10.64M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest21.46M

Days to Cover14.0

% of Float13.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2021-12-31

424B3 ATM 2026-04-27

EFFECT EFFECT 2026-04-24

S-3 SHELF 2026-04-21

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual OVID Dilution Snapshot

Ovid Therapeutics Inc. (OVID) has a DilutionScore of 75/100, rated High dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $60.0M.
Stored ATM program remaining capacity: $60.0M.
Recent SEC activity tracked for OVID: xbrl on 2026-06-30; 424B3 on 2026-04-27; EFFECT on 2026-04-24.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.